Neurocrine Biosciences Inc. (NBIX)

Last Three Months

15-Feb-24 -- 14-May-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Buy

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

33

0

0

+1

0

+2

0

+3

Two Year Chart

15-May-22 -- 14-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
15-Mar-24 5:19 PM View:	13-Mar-24 Planned Option Sale ($3.26M)	Pops Richard F Director		Neurocrine Biosciences Inc. - NBIX	0% 29.51K	0	0	--	--	Show Txns Hide Txns

17-Apr-24 5:19 PM View:	15-Apr-24 Planned Private Option Sale ($2.64M)	Benevich Eric Chief Commercial Officer		Neurocrine Biosciences Inc. - NBIX	0% 40.62K to 40.78K	0	0	--	--	Show Txns Hide Txns

15-Mar-24 5:25 PM View:	14-Mar-24 Planned Option Sale ($5.58M)	Morrow George J Director		Neurocrine Biosciences Inc. - NBIX	0% --	0	0	--	--	Show Txns Hide Txns

29-Feb-24 6:50 PM View:	27-Feb-24 Planned Option Sale ($1.09M)	Norwalk Leslie V Director		Neurocrine Biosciences Inc. - NBIX	0% --	0	0	--	--	Show Txns Hide Txns

08-May-24 4:26 PM View:	06-May-24 Planned Private Option Sale ($38.37K)	Delaet Ingrid Chief Regulatory Officer		Neurocrine Biosciences Inc. - NBIX	0% 7.51K	0	0	--	--	Show Txns Hide Txns